EarningsU.S. Physical Therapy, Inc. delivered solid Q3 results with patient visits at an all-time high for a Q3, affirming previous EBITDA guidance.
Investment RatingMaintaining an OUTPERFORM investment rating with a price target suggesting a 33% upside, supported by strong EBITDA estimates.
Revenue GrowthTotal revenue of $197.1 million exceeded both estimates and consensus, highlighting strong performance in patient and other revenue streams.